Fangfang Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fangfang Wei has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Katherine Gui-Min Jiang
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
2 shared publications - Keith Man-Chung Wong
Department of Chemistry Southern University of Science and Technology Shenzhen P. R. China
2 shared publications - Kenneth Kam-Wing Lo
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Hong Kong, P. R. China
2 shared publications Siye Wu
Department of Chemistry, Southern University of Science and Technology, 1088 Xueyuan Boulevard, Shenzhen 518055, P. R. China
2 shared publications- Guang-Xi Xu
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
1 shared publication - Lawrence Cho-Cheung Lee
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
1 shared publication
Latest Publications
- Open Access
- 5 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8197-8207
Mitochondria-targeting cyclometallated rhodium( iii ) complexes appended with two rhodamine units as Type I photosensitisers for bioimaging and photocytotoxicity applications by inducing pyroptosis
Cyclometallated rhodium( iii ) dirhodamine complexes targeted mitochondria and, upon photoirradiation, generated reactive oxygen species mainly via the Type I pathway, inducing gasdermin D-mediated pyroptosis through mitochondrial dysfunction.
- 5 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8197-8207
Open AccessMitochondria-targeting cyclometallated rhodium( iii ) complexes appended with two rhodamine units as Type I photosensitisers for bioimaging and photocytotoxicity applications by inducing pyroptosis
Cyclometallated rhodium( iii ) dirhodamine complexes targeted mitochondria and, upon photoirradiation, generated reactive oxygen species mainly via the Type I pathway, inducing gasdermin D-mediated pyroptosis through mitochondrial dysfunction.
- Open Access
- 8 October 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (46) , 22127-22135
Rhodamine-functionalised rhodium( iii ) complexes: dual role as bioimaging agents and controllable reactive oxygen species photosensitisers for photocytotoxicity applications
Compared to well-developed iridium(III) complexes, cyclometallated rhodium(III) complexes are underexplored as bioimaging reagents and photosensitisers, primarily due to the presence of non-emissive low-lying d–d excited states that limit their photophysical properties. In this work, a series of rhodamine-containing rhodium(III) complexes [Rh(N^C)2(bpy-Rho)](PF6)2 was designed and synthesised to circumvent this problem. The incorporation of a rhodamine unit into cyclometallated rhodium(III) complexes endowed them with effective bioimaging and considerable reactive oxygen species (ROS) sensitisation capabilities upon low-energy photoexcitation. Time-resolved transient absorption spectroscopy of the complexes revealed a long-lived dark triplet state of rhodamine that was responsible for the enhanced ROS photosensitisation. An energy cascade pathway was proposed for the complexes, involving energy transfer from a rhodamine singlet excited state (S1) to a Rh(N^C)2-based triplet excited state (T1’), and ultimately to the lowest-lying rhodamine-based triplet excited state (T1). Through a judicious choice of cyclometallating ligands, the energy cascade efficiency can be modulated to achieve a delicate balance between fluorescence and ROS photosensitisation. Furthermore, the complexes specifically accumulated in the mitochondria and showed excellent photocytotoxicity via inducing pyroptosis, highlighting their potential as theranostic agents for bioimaging and photodynamic therapy.
- 8 October 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (46) , 22127-22135
Open AccessRhodamine-functionalised rhodium( iii ) complexes: dual role as bioimaging agents and controllable reactive oxygen species photosensitisers for photocytotoxicity applications
Compared to well-developed iridium(III) complexes, cyclometallated rhodium(III) complexes are underexplored as bioimaging reagents and photosensitisers, primarily due to the presence of non-emissive low-lying d–d excited states that limit their photophysical properties. In this work, a series of rhodamine-containing rhodium(III) complexes [Rh(N^C)2(bpy-Rho)](PF6)2 was designed and synthesised to circumvent this problem. The incorporation of a rhodamine unit into cyclometallated rhodium(III) complexes endowed them with effective bioimaging and considerable reactive oxygen species (ROS) sensitisation capabilities upon low-energy photoexcitation. Time-resolved transient absorption spectroscopy of the complexes revealed a long-lived dark triplet state of rhodamine that was responsible for the enhanced ROS photosensitisation. An energy cascade pathway was proposed for the complexes, involving energy transfer from a rhodamine singlet excited state (S1) to a Rh(N^C)2-based triplet excited state (T1’), and ultimately to the lowest-lying rhodamine-based triplet excited state (T1). Through a judicious choice of cyclometallating ligands, the energy cascade efficiency can be modulated to achieve a delicate balance between fluorescence and ROS photosensitisation. Furthermore, the complexes specifically accumulated in the mitochondria and showed excellent photocytotoxicity via inducing pyroptosis, highlighting their potential as theranostic agents for bioimaging and photodynamic therapy.